Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe

समान संसाधन

• Advances in Pneumococcal Disease Prevention: 13-Valent Pneumococcal Conjugate Vaccine for Infants and Children
  द्वारा: Peter R. Paradiso
  प्रकाशित: (2011)
• Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines
  द्वारा: Daniel J. Isaacman, और अन्य
  प्रकाशित: (2009)
• Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
  द्वारा: Peterson, James T., और अन्य
  प्रकाशित: (2018)
• Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
  द्वारा: James T. Peterson, और अन्य
  प्रकाशित: (2018)
• Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
  द्वारा: Esposito, Susanna, और अन्य
  प्रकाशित: (2015)